{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:50:00Z","timestamp":1777884600222,"version":"3.51.4"},"reference-count":10,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Technology"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>Background: Nearly 10 billion doses of the various messenger ribonucleic acid (mRNA) and viral vector vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have been administered worldwide. Adverse drug reactions (ADRs) have been overwhelmingly mild to moderate in nature. Rare side effects have included myocarditis\/pericarditis, thrombosis with thrombocytopenia syndrome (TTS), Guillain-Barr\u00e9 Syndrome (GBS), and death. However, vaccine-related ADR data are still being collected using a variety of reporting systems. Purpose: We will describe a case of suspected mRNA coronavirus disease 2019 (COVID-19) booster\u2013related rhabdomyolysis in a woman who developed signs and symptoms 10 days after administration of the vaccine dose. With a Naranjo ADR probability score of 4, the vaccine was deemed to be a possible cause of our patient\u2019s rhabdomyolysis. Methods: A search of the VAERS (Vaccine Adverse Event Reporting System) mined in November 2021 revealed 386 reported cases of COVID-19 vaccine\u2013related rhabdomyolysis. However, system limitations make the utility of the information problematic. Conclusions: It is vitally important that clinicians, scientists, and patients are aware of rhabdomyolysis as a potential side effect of vaccination. Suspected vaccine-related ADRs should be promptly and accurately reported via VAERS or other surveillance systems to support the ongoing effort to ensure vaccine safety.<\/jats:p>","DOI":"10.1177\/87551225221093944","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T07:42:21Z","timestamp":1651563741000},"page":"247-250","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["A Possible Case of COVID-19 Booster Vaccine\u2013Associated Rhabdomyolysis and Acute Kidney Injury"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7703-778X","authenticated-orcid":false,"given":"Kendra","family":"Unger","sequence":"first","affiliation":[{"name":"Department of Family Medicine, West Virginia University School of Medicine, Morgantown, WV, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6005-4217","authenticated-orcid":false,"given":"Charles D.","family":"Ponte","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, West Virginia University School of Medicine, Morgantown, WV, USA"},{"name":"Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, Morgantown, WV, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Anderson","sequence":"additional","affiliation":[{"name":"West Virginia University School of Medicine, Morgantown, WV, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"bibr1-87551225221093944","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7039e4"},{"key":"bibr2-87551225221093944","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09185-4"},{"key":"bibr3-87551225221093944","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.12.061"},{"key":"bibr4-87551225221093944","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-021-01122-8"},{"key":"bibr5-87551225221093944","first-page":"61","volume":"90","author":"Gupta A","year":"2021","journal-title":"Ulster Med J"},{"key":"bibr6-87551225221093944","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.06.007"},{"key":"bibr7-87551225221093944","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.934399"},{"key":"bibr8-87551225221093944","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090956"},{"key":"bibr9-87551225221093944","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10768-3."},{"key":"bibr10-87551225221093944","unstructured":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Accessed February 21, 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548069\/."}],"container-title":["Journal of Pharmacy Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225221093944","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/87551225221093944","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225221093944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:31:01Z","timestamp":1777602661000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/87551225221093944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1177\/87551225221093944"],"URL":"https:\/\/doi.org\/10.1177\/87551225221093944","relation":{},"ISSN":["8755-1225","1549-4810"],"issn-type":[{"value":"8755-1225","type":"print"},{"value":"1549-4810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]}}}